{"corpus_id":17586572,"paper_sha":"4cf342084ca1483bf30bdac180b8b414ad8e7156","doi":"10.1038/tpj.2010.45","arxiv_id":null,"pmid":20548329,"pmcid":"2941547","mag_id":2026591106,"dblp_id":null,"acl_id":null,"title":"Gender-Related Survival Differences Associated With Polymorphic Variants of Estrogen Receptor Beta (ERβ) in Patients with Metastatic Colon Cancer","year":2010,"publication_date":"2010-05-10","venue":"The Pharmacogenomics Journal","journal":{"name":"The pharmacogenomics journal","pages":"375 - 382","volume":"11"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":64,"citation_count":16,"influential_citation_count":0,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"3' Untranslated Regions","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"}],"ui":"D020413"},{"d":"Adult","mj":false,"ui":"D000328"},{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Carcinoma","mj":false,"qs":[{"q":"genetics","mj":true,"ui":"Q000235"},{"q":"mortality","mj":false,"ui":"Q000401"},{"q":"secondary","mj":false,"ui":"Q000556"}],"ui":"D002277"},{"d":"Colonic Neoplasms","mj":false,"qs":[{"q":"genetics","mj":true,"ui":"Q000235"},{"q":"mortality","mj":false,"ui":"Q000401"},{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D003110"},{"d":"Disease-Free Survival","mj":false,"ui":"D018572"},{"d":"Estrogen Receptor beta","mj":false,"qs":[{"q":"genetics","mj":true,"ui":"Q000235"},{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D047629"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Gene Expression","mj":false,"ui":"D015870"},{"d":"Genetic Association Studies","mj":false,"ui":"D056726"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Microsatellite Repeats","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"}],"ui":"D018895"},{"d":"Middle Aged","mj":false,"ui":"D008875"},{"d":"Neoplasm Metastasis","mj":false,"ui":"D009362"},{"d":"Polymorphism, Genetic","mj":false,"ui":"D011110"},{"d":"Prognosis","mj":false,"ui":"D011379"},{"d":"Sex Factors","mj":false,"ui":"D012737"},{"d":"Treatment Outcome","mj":false,"ui":"D016896"}],"chemicals":[{"n":"3' Untranslated Regions","ui":"D020413","reg":"0"},{"n":"Estrogen Receptor beta","ui":"D047629","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Estrogen replacement therapy in women has shown a protective effect on the development of colonic carcinomas. Gender-related differences in the development of colonic carcinomas have also been reported. Estrogen receptor-β (ERβ) is expressed in colon carcinomas and has shown prognostic value in colon cancer patients. This study investigated an ERβ 3′ non-coding polymorphism associated with transcriptional activity to determine clinical outcome in patients with metastatic colon cancer. Genomic DNA from 318 metastatic colon cancer patients, 177 males and 141 females, were collected from 1992 to 2003. These patients were analyzed for CA repeat polymorphism of the ERβ gene. Gender-related survival differences were associated with an ERβ (CA)n repeat polymorphism (P for interaction=0.003, the likelihood ratio test). Female patients with any short <22 (CA)n repeat alleles had shorter overall survival (OS) compared with female patients who had both long ⩾22 (CA)n repeat alleles. In the male patients, the opposite OS difference was found. This study supports the role of an ERβ (CA)n repeat polymorphism as a prognostic marker in metastatic colon cancer; however, this prognostic factor had opposite implications based on gender.","claims":[{"public_id":"cl_8f628d0951d4a91d387f5bd57d93861d","status":"active","text":"ERβ (CA)n repeat polymorphism functions as a prognostic marker in metastatic colon cancer, with opposite implications by gender.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_8f628d0951d4a91d387f5bd57d93861d"},{"public_id":"cl_3d2e9cb196bca869e03bdc5185ed264b","status":"active","text":"Female patients with any short <22 (CA)n repeat alleles had shorter overall survival than female patients with both long ≥22 (CA)n repeat alleles.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_3d2e9cb196bca869e03bdc5185ed264b"},{"public_id":"cl_80ff3ac6fbe50250ec904c0f7c525349","status":"active","text":"Gender-related survival differences are associated with ERβ (CA)n repeat polymorphism in metastatic colon cancer.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_80ff3ac6fbe50250ec904c0f7c525349"},{"public_id":"cl_296d2529a729f63e8c99023325898607","status":"active","text":"Male patients showed the opposite overall survival difference with respect to the ERβ (CA)n repeat polymorphism.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_296d2529a729f63e8c99023325898607"}],"concepts":[{"public_id":"co_0b9ac5400016dec7596d6864657a3ca7","status":"active","name":"metastatic colon cancer","description":"Advanced colon cancer with metastatic disease, studied here in relation to survival outcomes.","types":["disease"],"aliases":["metastatic colorectal cancer"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0b9ac5400016dec7596d6864657a3ca7"},{"public_id":"co_0f72d7ff1369f5857b78299266e75392","status":"active","name":"overall survival","description":"The length of time patients survive after the clinical assessment or diagnosis.","types":["survival outcome"],"aliases":["OS"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0f72d7ff1369f5857b78299266e75392"},{"public_id":"co_27652bb909cf93548ab97705b2fc7c35","status":"active","name":"estrogen receptor beta","description":"A nuclear hormone receptor expressed in colon carcinoma cells.","types":["molecular target","receptor"],"aliases":["ERβ"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_27652bb909cf93548ab97705b2fc7c35"},{"public_id":"co_410f00d5d889ccc13c248ae36bf251c5","status":"active","name":"long ≥22 (CA)n repeat alleles","description":"ERβ CA-repeat alleles with 22 or more repeats.","types":["genetic marker"],"aliases":["long alleles"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_410f00d5d889ccc13c248ae36bf251c5"},{"public_id":"co_497c9d50c9304bd09a1df8cc07a2afae","status":"active","name":"ERβ (CA)n repeat polymorphism","description":"A polymorphic CA-repeat variant in the 3′ non-coding region of the estrogen receptor beta gene.","types":["genetic variant"],"aliases":["ERβ polymorphism","CA repeat polymorphism"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_497c9d50c9304bd09a1df8cc07a2afae"},{"public_id":"co_4f7941377b1114e8ec8c041c61f87353","status":"active","name":"female patients","description":"The female subgroup of patients analyzed for survival differences.","types":["patient subgroup"],"aliases":["women"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_4f7941377b1114e8ec8c041c61f87353"},{"public_id":"co_69afda332eeab3c54cae3e8d3c3bd962","status":"active","name":"short <22 (CA)n repeat alleles","description":"ERβ CA-repeat alleles with fewer than 22 repeats.","types":["genetic marker"],"aliases":["short alleles"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_69afda332eeab3c54cae3e8d3c3bd962"},{"public_id":"co_c389b013bcd40827a6aff9ba6acbdad9","status":"active","name":"male patients","description":"The male subgroup of patients analyzed for survival differences.","types":["patient subgroup"],"aliases":["men"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c389b013bcd40827a6aff9ba6acbdad9"},{"public_id":"co_c5ef71ce83698c579bee785129b4a37e","status":"active","name":"prognostic marker","description":"A biological feature used to indicate likely clinical outcome.","types":["clinical biomarker"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c5ef71ce83698c579bee785129b4a37e"},{"public_id":"co_d7a395946bcbfd5bb000a50292473826","status":"active","name":"gender-related survival differences","description":"Differences in survival outcomes between male and female patients.","types":["outcome difference"],"aliases":["sex-related survival differences"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d7a395946bcbfd5bb000a50292473826"}],"external_ids":{"DOI":"10.1038/tpj.2010.45","ArXiv":null,"PubMed":20548329,"PubMedCentral":"2941547","MAG":2026591106,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/17586572","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":633840,"paper_uid":"f4436836-d6ed-41c6-8252-0272983a7731","canonical_identity":{"paper_id":633840,"paper_uid":"f4436836-d6ed-41c6-8252-0272983a7731","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/17586572"}